Multimodality therapy for stage IIIA (N2) lung cancer: An overview

Chest

Volumn 103, Issue 4 SUPPL., 1993, Pages 356S-359S

  Ginsberg, R J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN; PLATINUM; VINCA ALKALOID;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HUMAN; INOPERABLE CANCER; LUNG CANCER; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW;

EID: 0027417444     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Gozetti G Mastrorilli M Bragaglia RB Surgical management of N2 lung cancer [abstract]. Lung Cancer 2 1986 96
2. Sawamura K Mori T Hasimoto S Results of surgical treatment of N2 disease [abstract]. Lung Cancer 2 1986 96
3. Martini N McCaughan B Bains MS Improved survival in resection for selected stage 3 lung cancer [abstract]. Lung Cancer 2 1986 97
4. Naruke T Suemasu K Ishikawa S Significance in surgery of lung cancer [abstract]. Lung Cancer 2 1986 96
5. Pearson FG DeLarue NC lives R Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 83 1982 1 11
6. The Lung Cancer Study Group (LCSG). Should subcarinal lymph nodes be routinely examined in patients with non-smallcell lung cancer? [abstract] Lung Cancer 2 1986 92
7. Watanabe Y Hayashi Y Shimizu J Mediastinal nodal involvement and the prognosis of non-small-cell lung cancer. Chest 100 1991 420 428
8. Naruke T Goya T Tsuchiya R Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 96 1988 440 447
9. Weisenberger TH Gail M Effects of postoperative mediastinal radiation on completely resected stage II and III epidermoid cancer of the lung: The Lung Cancer Study Group. N Engl J Med 315 1986 1377 1381
10. Holmes EC Hill LD Gail M A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung: The Lung Cancer Study Group. Ann Thorac Surg 202 1985 335 341
11. The Lung Cancer Study Group. The benefit of adjuvant treatment for resected local advanced non-small-cell lung cancer. J Clin Oncol 6 1988 9 17
12. Pisters KMW Kris MG Gralla RJ Preoperative chemotherapy in stage IIIA non-small cell lung cancer: an analysis of a trial in patients with clinically apparent mediastinal node involvement. Salmon SE Adjuvant therapy of cancer: VI. 1990 WB Saunders Company Philadelphia 133 137
13. Burkes RL Ginsberg RJ Shepherd FA Induction chemotherapy with mitomycin, vindesine and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase III Trial. J Clin Oncol 10 1992 580 586
14. Fossella F Ryan B Dhingra H Interim report of a prospective randomized trial of neoadjuvant chemotherapy plus surgery vs surgery alone for IIIA non-small-cell lung cancer (NSCLC) [abstract]. Proc Am Soc Clin Oncol 10 1991 240
15. Faber LP Kittle CF Warren WH Preoperative chemotherapy and irradiation for stage III non-small-cell lung cancer. Ann Thorac Surg 47 1989 669 675
16. Weiden P Piantadosi S Preoperative chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a phase II study of The Lung Cancer Study Group (LCSG) [abstract]. Proc Am Soc Clin Oncol 7 1988 197
17. Eagan RT Ruud C Lee RE Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III MO non-small-cell lung cancer. Cancer Treat Rep 71 1987 895 900
18. Strauss G Sherman L Mathisen D Concurrent chemotherapy (CT) and radiotherapy (RT) followed by surgery (S) in marginally resectable stage IIIA non-small cell carcinoma of the lung (NSCLC): a cancer and leukemia group B study [abstract]. Proc Am Soc Clin Oncol 7 1988 203
19. Albain K Rusch V Crowley J Concurrent cisplatin (DDP), VP-16, and chest irradiation (RT) followed by surgery for stages IIIa and IIIb non-small-cell lung cancer (NSCLC): a Southwest Oncology Group (SWOG) study (#8805) [abstract]. Proc Am Soc Clin Oncol 10 1991 244
20. Skarin A Jochelson M Sheldon T Neoadjuvant chemotherapy in marginally resectable stage III M0 non-small-cell lung cancer: long-term follow-up in 41 patients. J Surg Oncol 40 1989 266 274
21. Sherman D Strauss G Schwartz J Combined modality therapy for regionally advanced stage III non-small-cell carcinoma of the lung (NSCLC) employing neoadjuvant chemotherapy (CT), radiotherapy (RT), and surgery (S) [abstract]. Proc Am Soc Clin Oncol 6 1987 167
22. Cox JD Azarnia N Byhardt RW A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2: possible survival benefit with ≥60.6 Gy in favorable patients with stage III radiation therapy oncology group non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 8 1990 1543 1555
23. Dillman RO Seagren SL Propert KJ A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323 1990 940 945
24. Schaake-Koning C van den Bogaert W Dalesio O Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 326 1992 524 530
25. Pass HI Pogrebniak HW Steinberg SM Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 53 1992 992 996
26. Rosell R Gomez-Codina J Camps C Favorable outcome and aneuploidy reversion following neoadjuvant chemotherapy in stage IIIa non-small-cell lung cancer [abstract]. Proc Am Soc Clin Oncol 11 1992 287